XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
 12 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Cash Flows from Operating Activities:    
Net income (loss) $ (1,787,680) $ 960,972
Adjustments to reconcile net loss to net cash used in operating activities -    
Depreciation and amortization 20,970 23,368
Gain on sale of patents 0 (2,276,286)
Gain on sale of assets (4,498) (10,226)
Gain on settlement of accounts payable (76,149) 0
Provision for inventory write-down 19,337 14,033
Stock-based compensation expense 108,422 78,344
Non-cash provision for settlement of claims for liquidated damages 629,000 0
Non-cash interest expense 1,250 30,208
Changes in operating assets and liabilities -    
Accounts receivable, net 63,200 (193,076)
Inventories (232,610) (30,648)
Prepaid expenses (27,848) 3,945
Accounts payable (44,912) (129,079)
Customer advances 31,657 (29,905)
Accrued expenses 6,469 (27,165)
Net Cash Used In Operating Activities (1,293,392) (1,585,515)
Cash Flows from Investing Activities:    
Net proceeds from sale of patents 0 2,463,171
Proceeds from sale of assets 4,498 10,226
Purchases of property and equipment (11,061) (1,724)
Net cash provided by (used in) investing activities (6,563) 2,471,673
Cash Flows from Financing Activities:    
Gross proceeds from September 2012 private placement of common stock and warrants 2,500,015 0
Private placement expenses incurred and paid (308,896) 0
Payment of principal and interest on 10% Senior Convertible Notes (52,500) (759,791)
Proceeds from exercise of warrants to purchase common stock (50,000 shares) 50,000 0
Net cash provided by (used in) financing activities 2,188,619 (759,791)
Net increase in cash and cash equivalents 888,664 126,367
Cash and cash equivalents, beginning of year 145,923 19,556
Cash and cash equivalents, end of year 1,034,587 145,923
Supplemental Disclosure of Cash Flow Informatin:    
Cash paid during the year for income taxes 912 912
Supplemental Disclosure of Noncash Investing and Financing Activities:    
Issuance of common stock to satisfy deferred compensation obligations (245,326 shares) $ 0 $ 674,645